AI: The Future of Medical Writing

Without a doubt, advanced AI technologies are reimagining the future of medical writing. Historically, medical writers have been faced with inefficient, monotonous processes and have been seeking a solution to save time and ensure accuracy. Enter generative AI, which uses Large Language Models (LLMs) and advanced machine learning to create human-like text, pulling from existing data and experiences to generate new content.

In addition, generative AI technologies can automate parts of the clinical document landscape. This allows medical writers to be more productive and efficient, while helping to pass strict regulatory requirements – saving time and costs caused by human error. AI technologies can summarize large amounts of data, explain analysis in-depth and can model and scale human expertise at levels that have not been achieved before. 

Benefits of AI and Medical Writing

To maximize the benefits of AI, it’s critical to understand its potential. Further, the pharmaceutical industry could greatly benefit from generative AI, given the opportunity to cut costs and time in drug discovery. Gartner predicts that over 30% of new drugs and materials will be systematically discovered using generative AI techniques by 2025. 

Overall, AI can reduce workloads, repetition, and improve writing by eliminating errors and cross-checking information. Other benefits include:  

• Eliminating burnout by automating time consuming tasks and leveraging accurate data analysis 
• Providing data scientists, analysts and medical writers with peace of mind to focus on more strategic initiatives
• Producing large quantities of data consistently, quickly and at scale, while complying to industry rules/regulations 
• Accelerating drug development, providing companies with a competitive edge

Yseop Impacting the Future of Medical Writing

As individuals and companies continue to discover innovative ways to implement generative AI technologies, the impact will only continue to grow. Yseop is hyper focused on using generative AI in regulated industries and understands the high-stakes writing and review process for medical writing teams. Recently, Yseop launched Yseop Copilot, a digital colleague for medical writers that leverages pre-trained generative AI models (LLMs) specifically suited for the BioPharma industry. With Yseop Copilot, medical writers across hundreds of clinical trials have slashed writing times, while improving the consistency and reliability of reports quickly. Yseop believes that any AI system should be human centric and amplify human abilities.

Yseop’s mission is to get medicine into the hands of those who need it, faster and at scale. Discover how our AI-based platform accelerates the time it takes for drugs to get to market and eliminates the risk of human error in the data review process. With that, start your free automated content generation trial here to explore Yseop Copilot. 

To learn more about how Yseop’s generative AI solutions can accelerate your business, please contact hello@yseop.com.